HopeStage
Back to all studies
CompletedNCT02944994

Effectiveness of a Unified Transdiagnostic Treatment in Routine Care

It focuses on depression and currently lists study information in the United States.

Depression, Anxiety, ...OtherFrom 18 Years to 100 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 100 years.

Listed locations
Boston, United StatesSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateDecember 2014
Recruitment status
Completed
Enrollment listed in the registry
71
Sponsor
Boston University
Sponsor type
University
Study type
Other
Intervention type
OTHER
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 100 Years
Official registry ID
NCT02944994
Official title
Effectiveness of a Unified Transdiagnostic Treatment in Routine Clinical Care

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Boston University, a university.

Who was this study for?

Listed age limits: 18 years to 100 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me